Health News Releases

  • Today December 20
September 20, 2019 11:15
Solasia Announces Patient Registration Reached Target Number of Cases for Darinaparsin Phase 2 Pivotal Study for T-Cell Lymphoma
Solasia Pharma K.K. (TSE:4597, Headquarters: Tokyo, President & CEO: Yoshihiro Arai, hereinafter “Solasia”), a specialty pharmaceutical company based in Asia, today announced that patient registration
September 20, 2019 09:05
Consistent cardiovascular benefits shown with empagliflozin treatment regardless of the number of controlled cardiovascular risk factors
Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced results of a post-hoc analysis of the landmark EMPA-REG OUTCOME® trial that were presented at the 55th Annual Meeting of the
September 19, 2019 10:23
Three Hospital Systems Earn Five-Star Award from Patient Safety Movement Foundation
On the first World Patient Safety Day, the Patient Safety Movement Foundation (PSMF) announces that it has awarded Dignity Health, MedStar Health and the UPMC with its five-star award for making commi
September 16, 2019 13:50
Hansoh Pharma and Atomwise Launch Strategic AI Drug Discovery Collaboration for Multiple Therapeutic Areas
Hansoh Pharmaceutical Group Company Limited (“Hansoh Pharma”), a leading biopharmaceutical company in China, and Atomwise, Inc. (“Atomwise”), the leader in artificial intelligence (AI) for drug discov
September 16, 2019 09:26
Aptorum Group Has Initiated IND-Enabling Studies For Its ALS-4 Small Molecule Candidate For The Treatment Of Infections Caused By Staphylococcus Aureus Including MRSA
Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces that it has initiat
September 16, 2019 09:19
Aptorum Group Announces the Development of Microbiome Drug Candidate Targeting Obesity and Repurposed Drug Candidates Targeting Neuroblastoma
Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces the development of
September 10, 2019 09:04
Data from Ozanimod Clinical Development Program in Relapsing Forms of Multiple Sclerosis to Be Presented at the 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis
Celgene Corporation (NASDAQ:CELG) today announced it will present 13 scientific abstracts, including new analyses from the Phase 3 ozanimod clinical development program in adults with relapsing forms
September 09, 2019 11:03
Walgreens Boots Alliance Appoints Global Chief Information Officer
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced Francesco Tinto was named global chief information officer (CIO) and senior vice president at the company, which ranks #17 on the Fortune 5
September 05, 2019 17:00
After Successful Technical Feasibility the Swiss Company SAV-IOL is Now Seeking Investors for Smart Active Intraocular Lens Project for Cataract Surgery
SAV-IOL (Swiss Advanced Vision) is moving forward with the development of the R-TASC Project, the first electronic intraocular lens (IOL) with real-time autofocus, aimed to fully restore the vision po
September 05, 2019 10:12
GVK BIO Announces the Promotion of Sudhir Kumar Singh to Chief Operating Officer and Appointment of Ramesh Subramanian as the New Chief Commercial Officer of GVK BIO
GVK BIO, a leading global Contract Research and Development Organisation (CRDO), is pleased to announce the promotion of Sudhir Kumar Singh, Ph.D., to the position of Chief Operating Officer and the a
September 04, 2019 17:43
Boehringer Ingelheim Expands KRAS Cancer Program with Lupin’s Clinical Stage MEK Inhibitor Compound
Boehringer Ingelheim and Lupin Limited (Lupin) today announced a licensing, development and commercialization agreement for Lupin’s MEK inhibitor compound (LNP3794) as a potential targeted therapy for
September 04, 2019 17:40
Results from RE-SPECT CVT® published - first trial of NOAC in cerebral venous thrombosis
Boehringer Ingelheim today announced the publication of primary analysis from RE-SPECT CVT®, the first exploratory, prospective, randomised controlled study of a NOAC in patients with blood clots in t
September 04, 2019 11:12
GN Hearing Becomes World’s First to Support Direct Android Streaming to Hearing Devices Using Bluetooth Low Energy
GN Hearing, the global leader in hearing aid connectivity, and Cochlear, the global leader in implantable hearing solutions, together with Google, today announce world-first support for direct streami
September 03, 2019 17:10
Boehringer Ingelheim and Zealand Pharma Advance Dual-Acting GLP-1/glucagon Agonist BI 456906 to Phase 2 Clinical Testing in Obesity/Diabetes
Boehringer Ingelheim and Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL), have announced that Boehringer Ingelheim plans to initiate Phase 2 development of the GLP-1/glucagon dual agonist BI 456906, whi
September 02, 2019 10:47
Concept Medical Inc. Granted ‘Breakthrough Device Designation’ From the FDA for Its MagicTouch AVF Sirolimus Coated Balloon
Concept Medical Inc. (CMI) has been granted “Breakthrough Device Designation” from the U.S. Food and Drug Administration (FDA) for MagicTouch AVF, its Sirolimus drug-coated balloon (DCB) catheter, for
August 30, 2019 17:20
Anniversary of the pivotal RE-LY® trial marks a decade of innovation for stroke prevention in AF patients
Boehringer Ingelheim today announces the ten-year anniversary of the RE-LY® trial publication[1-3] recognising the contribution made in the decade since by patients, healthcare professionals (HCPs) an
August 29, 2019 16:29
PCI Strengthens Position in Europe with Investment in Ireland
PCI Pharma Services (PCI), a leading biopharmaceutical outsourcing services provider, has solidified its leadership position in the EU with strategic investment to deepen its presence in Ireland and e
August 29, 2019 11:01
The Mary Kay FoundationSM and UT Southwestern Partner to End Cancers Impacting Women Globally
The Mary Kay FoundationSM, a decades-long leader in the charge to eliminate cancers affecting women, recently announced a $500,000 grant to fund a groundbreaking global fellowship program with long-ti
August 29, 2019 10:45
GABA Resurgence: Pharma Foods International Releases Study Proving Unexpected Benefit to Muscle Growth From a Valued Amino Acid
Pharma Foods International Co. Ltd. has made available for publication its first-ever study proving that supplementing a post-exercise whey protein regimen with their naturally-produced flagship produ
August 27, 2019 16:11
Study Investigates the Utility of Masimo ORi™, Oxygen Reserve Index, to Reduce Hyperoxia in Critically Ill Patients
Masimo (NASDAQ: MASI) announced today that in a randomized controlled study involving 150 ICU patients recently published as a letter in Intensive Care Medicine, researchers investigated whether monit
August 23, 2019 11:48
Registration for 2020 World Patient Safety, Science & Technology Summit Now Open
Registration for the Patient Safety Movement’s (PSMF) 2020 World Patient Safety, Science & Technology Summit is now open. Co-convened with the International Society for Quality in Health Care (ISQua),
August 20, 2019 16:00
Sustainable Manufacturing Practices Needed to Combat Growing Antimicrobial Resistance
Centrient Pharmaceuticals, a global leader in sustainable antibiotics manufacturing, in partnership with Indian Institute of Technology - Delhi, organized a workshop on ‘Sustainability Through Excelle
August 19, 2019 11:55
Anesthesia Patient Safety Foundation and Patient Safety Movement Foundation Offer $100,000 Patient Safety Curriculum Award
The Anesthesia Patient Safety Foundation (APSF), in partnership with the Patient Safety Movement Foundation (PSMF), is now accepting proposals for the Patient Safety Curriculum Award. The $100,000 awa
August 19, 2019 10:41
2019 Edogawa NICHE Prize Awarded to Dr. Steven Rosenberg for His Pioneering Feat in Tackling Cancer with Immunotherapy
The Edogawa NICHE Committee today announced that the 2019-Edogawa NICHE Prize (www.edogawanicheprize.org) has been awarded to Dr. Steven A. Rosenberg, for his pioneering work in developing effective a
August 14, 2019 15:37
Concept Medical Granted “Breakthrough Device Designation” by FDA for MagicTouch PTA Sirolimus Coated Balloon
Concept Medical Inc. (CMI) has been granted “Breakthrough Device Designation” from the U.S. Food and Drug Administration (FDA) for MagicTouch PTA (Percutaneous Transluminal Angioplasty), its Sirolimus
25 per page50 per page75 per page100 per page